Logo

sepsis

Immunexpress Begins US Commercialization of Near-Patient Sepsis Diagnostic Test
Premium

The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis. 

Blu Biotech Sniffing Out Infections, Cancer With Multi-Disease Breathalyzer
Premium

The firm is developing a shoebox-size gas chromatography instrument that could be used for routine screenings and critical illness detection and monitoring.

Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium

The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.

DeepUll Inks €20M Loan Agreement With European Investment Bank

The loan will finance DeepUll's research, development, and innovation efforts for its culture-free diagnostics platform for the early identification of sepsis.

Cepheid Nabs CE Mark for Group B Strep Test

The PCR-based Xpert Xpress GBS test can help screen pregnant women for Streptococcus infections that can lead to early-onset neonatal sepsis.

Nov 7, 2022

Oxford, Sanger Institute Researchers Draw on Gene Expression Testing for Sepsis Risk Algorithm
Premium

Oct 28, 2022

DeepUll Developing Multiplex PCR System to Serve as Future Frontline Sepsis Test
Premium

Oct 20, 2022

Sepsis Testing Startup DeepUll Raises €13M

Oct 20, 2022

Day Zero Diagnostics Secures Additional $8.2M From CARB-X

Aug 10, 2022

VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis

Jul 6, 2022

T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce

May 24, 2022

BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel

Apr 1, 2022

T2 Biosystems Exercises BARDA Contract Option Valued at $4.4M

Apr 1, 2022

UK Startup Great North Research & Innovation Awarded $319K to Develop Point-of-Care Sepsis Diagnostic
Premium

Jan 28, 2022

Streck Gets FDA Clearance for BioFire Sepsis Panel Control Material

Nov 30, 2021

Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay

Nov 4, 2021

T2 Biosystems Q3 Revenues Jump 42 Percent

Oct 4, 2021

BARDA Exercises $6.4M Option on T2 Biosystems Contract

Sep 9, 2021

UK Startup Presymptom Health Developing Host-Response Prognostic Test for Sepsis
Premium

Aug 5, 2021

T2 Biosystems Q2 Revenues More Than Double, Beat Estimates

May 20, 2021

With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing
Premium

May 7, 2021

T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy
Premium

Apr 27, 2021

CARB-X Awards GenomeKey Up to $9.5M to Develop Rapid Diagnostic Test for Sepsis

Apr 20, 2021

Baebies Awarded up to $11.6M in CARB-X Funding for Neonatal Sepsis Test

Mar 16, 2021

Inflammatix Raises $102M in Series D Financing to Continue Development of Immune-Response Tests

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.